Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn’s Disease during One-Year Follow-Up

Background: Seven weeks of high-dose vitamin D treatment decreases intestinal IL17A and IFN-γ mRNA expression in active Crohn’s disease (CD). In this follow-up study, we investigated whether seven-week vitamin D treatment affected the infliximab response in the following 45 weeks compared to placebo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nutrients
Main Authors: Bendix, Mia, Dige, Anders, Jørgensen, Søren Peter, Dahlerup, Jens Frederik, Bibby, Bo Martin, Deleuran, Bent, Agnholt, Jørgen
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8065492/
https://ncbi.nlm.nih.gov/pubmed/33810258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/nu13041083
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados